TECX
NASDAQ
$32.07
AvroBio Inc (TECX)
Tectonic Therapeutic, Inc. engages in the discovery of antibodies and other biologic drugs targeting G-protein-coupled receptors (GPCRs) to develop novel therapies for patients inadequately served by current treatments. The company is headquartered in Watertown, Massachusetts.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $78.44 (+144.59%)
Market Cap
$612M
Free Cash Flow Yield
-10.72%
Beta (5Y)
1.61
Price Chart
Valuation
Market Cap$612M
P/B2.85
Profitability
EBITDA-$92M
EPS-$4.45
Financial Health
Free Cash Flow Yield-10.72%
Growth & Risk
EPS 5Y CAGR-34.69%
FCF 5Y CAGR-8.88%
Beta (5Y)1.61
Sharpe Ratio0.77